Role of axl in preeclamptic EPCs functions

Abstract

Axl encodes the tyrosine-protein kinase receptor, participating in the proliferation and migration of many cells. This study examined the role of Axl in functions of endothelial progenitor cells (EPCs). Axl was detected by RT-PCR and Western blotting in both placentas and EPCs from normal pregnancy and preeclampsia patients. The Axl inhibitor, BMS777-607, was used to inhibit the Axl signalling pathway in EPCs. Cell proliferation, differentiation, migration and adhesion were measured by CCK-8 assay, cell differentiation assay, Transwell assay, and cell adhesion assay, respectively. Results showed the expression levels of Axl mRNA and protein were significantly higher in both placentas and EPCs from preeclampsia patients than from normal pregnancy (P<0.05). After treatment with BMS777-607, proliferation, differentiation, migration and adhesion capability of EPCs were all significantly decreased. Our study suggests Axl may play a role in the function of EPCs, thereby involving in the pathogenesis of preeclampsia.

Keywords

Axl / endothelial progenitor cells / preeclampsia

References

[1] RobertsJM, CooperDW. Pathogenesis and genetics of pre-eclampsia. Lancet, 2001, 357(9249): 53-56 PMID: 11197372

[2] GynecologistsTACoOa. Hypertension in pregnancy. Obstet Gynecol, 2013, 122(5): 1122-1131

[3] SzperaAG, BreborowiczGH. Endothelial dysfunction in the pathogenesis of pre-eclampsia. Front Biosci (Landmark Ed), 2014, 19: 734-746

[4] McMasterMT, ZhouY, FisherSJ. Abnormal placentation and the syndrome of preeclampsia. Semin Nephrol, 2004, 24(6): 540-547 PMID: 15529288

[5] RobertsJM. Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol, 1998, 16(1): 5-15 PMID: 9654603

[6] HattoriK, TjwaM, MoonsL, et al. . Revascularization of ischemic tissues by PIGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med, 2002, 8(8): 831-840

[7] HurJ, YoonCH, KimHS, et al. . Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol, 2004, 24(2): 288-293 PMID: 14699017

[8] BonarosN, SondermeijerH, WiedemannD, et al. . Downregulation of the CXC chemokine receptor 4/Stromal cell-derived factor 1 pathway enhances myocardial neovascularization, cardiomyocytes survival and functional recovery after myocardial infarction. Thorac Cardiovasc Surg, 2011, 142(3): 687-696

[9] TakahashiT, KalkaC, MasudaH, et al. . Ischemia-and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med, 1999, 5(4): 434-8 PMID: 10202935

[10] HillJM, ZalosG, HalcoxJP, et al. . Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med, 2003, 348(7): 593-600 PMID: 12584367

[11] HuppertzB. Placental origins of preelampsia challenging the current hypothesis. Hypertension, 2008, 51(4): 970-975 PMID: 18259009

[12] LuppiP, PowersRW, VermaV, et al. . Maternal circulating CD34+ VEGFR-2+ and CD133+ VEGFR-2+ progenitor cells increase during normal pregnancy but are reduced in women with preeclampsia. Reprod Sci, 2010, 17(7): 643-652 PMID: 20360595 PMCID: 2893245

[13] LinC, RajakumarA, PlymireDA, et al. . Maternal endothelial progenitor colony-forming units with macrophage characteristics are reduced in preeclampsia. Am J Hypertens, 2009, 22(9): 1014-1019 PMID: 19498340 PMCID: 2830891

[14] HeimrathJ, PaprockaM, CzwkanskiA, et al. . Pregnancy-induced hypertension is accompanied by decreased number of circulating endothelial cells and circulating endothelial progenitor cells. Arch Immunol Ther Exp (Warsz), 2014, 62(4): 353-356

[15] ChouY, ZhuJ, ZouL, et al. . Changes in number and biological function of endothelia progenitor cells in hypertension disorder complicating pregnancy. J Huazhong Univ Sci Technol Med Sci, 2008, 28(6): 670-673

[16] StittTN, ConnG, GoreM, et al. . The anticoagulation factor protein S and its relative, Gas6, are ligands for the Tyro 3/Axl family of receptor tyrosine kinases. Cell, 1995, 80(4): 661-670 PMID: 7867073

[17] WuYM, RobinsonDR, KungHJ, et al. . Signal pathways in up-regulation of chemokines by tyrosine kinase MER/NYK in prostate cancer cells. Cancer Res, 2004, 64(20): 7311-7320 PMID: 15492251

[18] ChungBI, MalkowiczSB, NguyenTB, et al. . Expression of the proto-oncogene Axl in renal cell carcinoma. DNA Cell Biol, 2003, 22(8): 533-540 PMID: 14565870

[19] HollandSJ, PowellMJ, FranciC, et al. . Multiple roles for the receptor tyrosinekinase Axl in tumor formation. Cancer Res, 2005, 65(20): 9294-9303 PMID: 16230391

[20] HasanbasicI, CuerquisJ, VarnumB, et al. . Intracellular signaling pathways involved in Gas6-Axl-mediated survival of endothelial cells. Am J Physiol Heart Circ Physiol, 2004, 287(3): H1207-1213 PMID: 15130893

[21] GallicchioM, MitolaS, ValdembriD, et al. . Inhibition of vascular endothelial growth factor receptor 2-mediated endothelial cell activation by Axl tyrosine kinase receptor. Blood, 2005, 105(5): 1970-1976 PMID: 15507525

[22] HOUL, ZhuY, MaX, et al. . Serum protein microarray analysis of patients withpreeclampsia. Mol Med Re, 2012, 6(1): 83-87

[23] AsaharaT, MuroharaT, SullivanA, et al. . Isolation of putative progenitor endothelial cells for angiogenesis. Science, 1997, 275(5302): 964-967 PMID: 9020076

[24] HurJ, YangHM, YoonCH, et al. . Identification of a novel role of T cells in postnatal vasculogenesis: characterization of endothelial progenitor cell colonies. Circulation, 2007, 116(15): 1671-1682 PMID: 17909106

[25] YanT, LiuY, CuiK, et al. . MicroRNA-126 regulates EPCs function: Implications for a role of miR-126 in preeclampsia. J Cell Biochem, 2013, 114(9): 2148-2159 PMID: 23553946

[26] LingerRM, KeatingAK, ErapHS, et al. . Taking aim at Mer and receptor tyrosine kinases as novel therapeutic targets in solid tumors. Expert Opin Ther Targets, 2010, 14(10): 1073-1090 PMID: 20809868 PMCID: 3342018

[27] UshiyamaS, LaueTM, MooreKL, et al. . Structural and functional characterization of monomeric soluble P-selectin and comparison with membrane P-selectin. J Biol Chem, 1993, 268(20): 15229-15237 PMID: 7686912

[28] BerezinAE, KremzerAA. Circulating endothelial progenitor cells as markers for severity of ischemic chronic heart failure. J Card Fail, 2014, 20(6): 438-447 PMID: 24594088

[29] FridellYW, VillaJJ, AttarEC, et al. . Gas6 induces Axl-mediated chemotaxis of vascular smooth muscle cells. J Biol Chem, 1998, 273(12): 7123-7126 PMID: 9507025

[30] McCloskeyP, FridellYW, AttarE, et al. . Gas6 mediates adhesion of cells expressing the receptor tyrosine kinase Axl. J Biol Chem, 1997, 272(37): 23285-23291 PMID: 9287338

[31] GoruppiS, RuaroE, VarnumB, et al. . Requirement of phosphatidylinositol3-kinase-dependent pathway and Src for Gas6–Axl mitogenic and survival activities in NIH 3T3 fibroblasts. Mol Cell Biol, 1997, 17(8): 4442-4453 PMID: 9234702 PMCID: 232298

[32] KorshunovVA, MohanAM, GeorgerMA, et al. . Axl, a receptor tyrosine kinase, mediates flow-induced vascular remodeling. Circ Res, 2006, 98(11): 1446-1452 PMID: 16627783

[33] ChungBI, MalkowiczSB, NguyenTB, et al. . Expression of the proto-oncogene Axl in renal cell carcinoma. DNA Cell Biol, 2003, 22(8): 533-540 PMID: 14565870

[34] MelaragnoMG, WuthrichDA, PoppaV, et al. . Increased expression of Axl tyrosine kinase after vascular injury and regulation by G protein-coupled receptor agonists in rats. Circ Res, 1998, 83(7): 697-704 PMID: 9758639

[35] EkmanC, StenhoffJ, DahlbäckB. Gas6 is complexed to the soluble tyrosine kinase receptor Axl in human blood. J Thromb Haemost, 2010, 8(4): 838-844 PMID: 20088931

[36] ShankarSL, O’guinK, KimM, et al. . Gas6/Axl signaling activates the phosphatidylinositol3-kinase/Akt1 survival pathway to protect oligodendrocytes from tumor necrosis factor alpha-induced apoptosis. J Neurosci, 2006, 26(21): 5638-5648 PMID: 16723520

[37] LiY, YeX, TanC, et al. . Axl as a potential therapeutic target in cancer: role of Axl in tumor growth, metastasis and angiogenesis. Oncogene, 2009, 28(39): 3442-3455 PMID: 19633687